润肠颗粒对小鼠便秘的改善作用及机制

黄梦琴; 王雪松; 甘雨涵; 卢诗勤; 邓琪琪; 朱青; 郭姣

doi:10.6039/j.issn.1001-0408.2024.02.07

您当前的位置：

首页 >

文章列表页 >

润肠颗粒对小鼠便秘的改善作用及机制

药学研究 | 更新时间：2024-01-24

- 润肠颗粒对小鼠便秘的改善作用及机制
- Improvement effects of Runchang granules on the constipation in mice and its mechanism
- 中国药房 2024年35卷第2期页码：160-165
- 作者机构：
  
  广东药科大学中医药研究院/广东省代谢病中西医结合研究中心/糖脂代谢病教育部重点实验室/广东省代谢性疾病中医药防治重点实验室，广州　510006
- 作者简介：
  
  硕士研究生。研究方向：中药药效评价与应用。 E-mail：2112048009@gdpu.edu.cn
  教授，硕士生导师，博士。研究方向：中医药防治代谢性疾病。E-mail：zyq973@hotmail.com
- 基金信息：
  
  广东省基础与应用基础研究重大项目(2019B0-30302005)
- DOI：10.6039/j.issn.1001-0408.2024.02.07
  中图分类号： R965
- 纸质出版日期：2024-01-30，
  
  收稿日期：2023-05-29，
  
  修回日期：2023-12-17，
扫描看全文
黄梦琴,王雪松,甘雨涵等.润肠颗粒对小鼠便秘的改善作用及机制 ^Δ[J].中国药房,2024,35(02):160-165.

HUANG Mengqin,WANG Xuesong,GAN Yuhan,et al.Improvement effects of Runchang granules on the constipation in mice and its mechanism[J].ZHONGGUO YAOFANG,2024,35(02):160-165.
黄梦琴,王雪松,甘雨涵等.润肠颗粒对小鼠便秘的改善作用及机制 ^Δ[J].中国药房,2024,35(02):160-165. DOI： 10.6039/j.issn.1001-0408.2024.02.07.

HUANG Mengqin,WANG Xuesong,GAN Yuhan,et al.Improvement effects of Runchang granules on the constipation in mice and its mechanism[J].ZHONGGUO YAOFANG,2024,35(02):160-165. DOI： 10.6039/j.issn.1001-0408.2024.02.07.

摘要

目的

探讨润肠颗粒对小鼠便秘的改善作用及潜在机制。

方法

将小鼠随机分为正常对照组、模型组、润肠颗粒低剂量组（5 g/kg）、润肠颗粒高剂量组（10 g/kg）和莫沙必利组（0.003 g/kg，阳性对照），每组6只。后4组小鼠灌胃洛哌丁胺（0.004 g/kg），每天2次，持续给药3 d后开始药物治疗，正常对照组和模型组小鼠灌胃纯水，各药物组小鼠灌胃相应药物，连续给药7 d。末次给药后，测定小鼠粪便含水量和肠道推进率，观察结肠和回肠组织结构以及结肠黏液分泌量，检测结肠组织中酪氨酸激酶受体c-kit、黏蛋白2（MUC2）、干细胞因子（SCF）蛋白表达水平以及炎症因子[肿瘤坏死因子α（TNF-α）、白细胞介素6（IL-6）、IL-1β、诱导型一氧化氮合成酶（iNOS）]和促进肠道运动相关因子[神经型一氧化氮合酶（nNOS）、平滑肌肌球蛋白轻链激酶（smMLCK）、5-羟色胺受体4（5-HT

R）、MUC2、SCF、c-kit]mRNA表达水平。

结果

与模型组比较，润肠颗粒低、高剂量组和莫沙必利组小鼠粪便含水量，肠道推进率，结肠组织中c-kit蛋白表达水平和MUC2、SCF蛋白相对表达量以及促进肠道运动相关因子（润肠颗粒低剂量组nNOS和SCF除外）mRNA相对表达量均显著增加（

＜0.05或

＜0.01）；炎症因子mRNA相对表达量均显著降低（

＜0.05或

＜0.01）；结肠和回肠损伤均改善；润肠颗粒高剂量组小鼠结肠黏液分泌量显著增加（

＜0.01）。

结论

润肠颗粒具有润肠通便的作用，能够改善小鼠便秘，其润肠机制可能与促进结肠黏液分泌和MUC2表达有关，其通便机制可能与激活SCF/c-kit信号通路有关。

Abstract

OBJECTIVE

To investigate the improvement effects of Runchang granules on the constipation in mice and its potential mechanism.

METHODS

The mice were randomly divided into normal control group， model group， Runchang granules low-dose and high-dose groups （5， 10 g/kg）， mosapride group （0.003 g/kg， positive control）， with 6 mice in each group. The latter 4 groups were given loperamide intragastrically （0.004 g/kg）， twice a day， for 3 consecutive days. Normal control group and model group were given purified water intragastrically， and administration groups were given relevant medicine intragastrically for 7 consecutive days. After the last medication， fecal moisture content and intestinal motility of mice were determined， while the structures of colon and ileum， and the secretion of colonic mucus were observed. Protein expressions of tyrosine kinase receptor （c-kit）， mucin 2 （MUC2） and stem cell factor （SCF） were determined in colon； meanwhile， the mRNA expression levels of inflammatory factors [tumor necrosis factor-α （TNF-α）， interleukin-6 （IL-6）， IL-1β， inducible nitric oxide synthase （iNOS）] as well as factors related to promoting intestinal motility [neuronal nitric oxide synthase （nNOS）， smooth muscle myosin light

chain kinase （smMLCK）， 5-hydroxytryptamine 4 receptor （5-HT

R）， MUC2， SCF， c-kit] were determined.

RESULTS

Compared with model group， the fecal water content， intestinal propulsion rate， protein expression of c-kit in colon， relative expressions of MUC2 and SCF protein， and mRNA expressions of factors related to promoting intestinal motility （except for nNOS and SCF in Runchang granules low-dose group） were all increased significantly in Runchang granules low-dose and high-dose groups， and mosapride group （

＜0.05 or

＜0.01）. mRNA expression levels of inflammatory factors were decreased significantly（

＜0.05 or

＜0.01）. Both colon and ileum injuries improved， and the secretion of colon mucus was increased significantly in Runchang granules high-dose group （

＜0.01）.

CONCLUSIONS

Runchang granules have laxative effect and can improve constipation in mice， and its mechanism may be related to the promotion of the secretion of colon mucus and MUC2 expression， and the activation of SCF/c-kit signaling pathway.

关键词

润肠颗粒便秘黏蛋白2干细胞因子/酪氨酸激酶受体信号通路

Keywords

constipationmucin 2stem cell factor/c-kit signaling pathway

references

郭姣. 一种治疗便秘的中药组合物及其制备方法：CN114869942B[P]. 2023-06-06.

GUO J. A traditional Chinese medicine combination for treating constipation and its preparation method：CN114869942B[P]. 2023-06-06.

WU H，CHEN Y J，HUANG B B，et al. Aster tataricus alleviates constipation by antagonizing the binding of acetylcholine to muscarinic receptor and inhibiting Ca2+ influx[J]. Biomedecine Pharmacother，2021，133：111005.

ZHANG X Y，YANG H B，ZHENG J P，et al. Chitosan oligosaccharides attenuate loperamide-induced constipation through regulation of gut microbiota in mice[J]. Carbohydr Polym，2021，253：117218.

李翔子，李市荣，杨田野，等. 首荟通便胶囊对慢性传输性便秘小鼠肠道屏障的影响[J]. 中草药，2022，53（5）：1458-1462.

LI X Z，LI S R，YANG T Y，et al. Effect of Shouhui Tongbian Capsules on intestinal barrier in mice with chronic transit constipation[J]. Chin Tradit Herb Drugs，2022，53（5）：1458-1462.

LEE M C，HA W，PARK J，et al. Effects of Lizhong Tang on gastrointestinal motility in mice[J]. World J Gastroenterol，2016，22（34）：7778-7786.

LI X M，LIU Y，GUAN W，et al. Physicochemical properties and laxative effects of polysaccharides from Anemarrhena asphodeloides Bge. in loperamide-induced rats[J]. J Ethnopharmacol，2019，240：111961.

HANSSON G C. Role of mucus layers in gut infection and inflammation[J]. Curr Opin Microbiol，2012，15（1）：57-62.

VANCAMELBEKE M，VERMEIRE S. The intestinal barrier：a fundamental role in health and disease[J]. Expert Rev Gastroenterol Hepatol，2017，11（9）：821-834.

GIORGIO R D，RUGGERI E，STANGHELLINI V，et al. Chronic constipation in the elderly：a primer for the ga- stroenterologist[J]. BMC Gastroenterol，2015，15：130.

DICKSON E J，HEREDIA D J，MCCANN C J，et al. The mechanisms underlying the generation of the colonic migrating motor complex in both wild-type and nNOS knockout mice[J]. Am J Physiol Gastrointest Liver Physiol，2010，298（2）：G222-G232.

HE W Q，PENG Y J，ZHANG W C，et al. Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice[J]. Gastroenterology，2008，135（2）：610-620.

JEON Y J，LEE J S，CHO Y R，et al. Banha-sasim-Tang improves gastrointestinal function in loperamide-induced functional dyspepsia mouse model[J]. J Ethnopharmacol，2019，238：111834.

TAKAKI M. Gut pacemaker cells：the interstitial cells of Cajal（ICC）[J]. Nihon Heikatsukin Gakkai Kikanshi，2003，39（5）：137-161.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据